Clinical Drug Experience Knowledgebase

asparaginase (elspar) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

cytarabine (cytosar-u) (2 trials)

daunorubicin (cerubidine) (1 trial)

doxorubicin (Doxil) (1 trial)

leucovorin (2 trials)

mercaptopurine (purinethol) (1 trial)

naltrexone (revia) (2 trials)

prednisone (meticorten) (2 trials)

tioguanine (Lanvis) (1 trial)

urea (2 trials)

vincristine (oncovin) (2 trials)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)

autologous hematopoietic cell (1 trial)

busulfan (myleran) (1 trial)

carboplatin (paraplatin) (1 trial)

carmustine (bicnu) (1 trial)

cyclosporine (sandimmune) (1 trial)

etoposide (vepesid) (1 trial)

idarubicin (idamycin) (1 trial)

ifosfamide (ifex) (1 trial)

lomustine (1 trial)

melphalan (alkeran) (1 trial)

mitoxantrone (novantrone) (1 trial)

peripheral blood hematopoietic cell (1 trial)

thiotepa (1 trial)

vinblastine (velban) (1 trial)